Tag: Sean N Parker Center for Allergy and Asthma Research
COUR Announces First In-Human Dosing in Proof-of-Concept Trial of CNP-201 to...
CNP-201 is a nanoparticle containing peanut protein that aims to eliminate allergic responses.
Study: PEG Linked to Rare Allergic Reactions to mRNA COVID-19 Vaccines
An ingredient used in many products including lotions and shampoos, may be the cause of rare allergic reactions to the mRNA COVID-19 vaccines.
Watch: Dr Kari Nadeau Discusses Food Allergy Prevention and Treatment at...
Well worth your time if you have food allergies, care for someone who does, or are pregnant or considering pregnancy in the near future.
Study: Antibody Injection Stops Peanut Allergy for 2 to 6 Weeks
A Stanford-led pilot study has provided early evidence that an antibody is a safe, effective and rapid food allergy treatment.
Must Hear: Interview with Stanford Immunologist Dr Kari Nadeau – Defeating...
Dr Kari Nadeau, who runs the Sean Parker Center for Allergy and Asthma Research at Stanford University, takes us on a tour of food...
Positive Mindset About Side Effects of Peanut OIT Improves Outcomes
Framing side effects as positive signs of healing significantly reduced anxiety in young children.
SAFE + FAIR Enters the Gluten Free Snack World with New...
The Safe + Fair Food Company has just released a new line of gluten-free chips that are free from peanuts, tree nuts, egg and other top allergens.
Study: Drug Increases Speed and Safety of OIT for Multiple Allergies
Combining omalizumab with OIT is safe and effective for treating multiple food allergies simultaneously.
Safe + Fair to Donate 3% of Proceeds to Sean N...
Will fund research of treatments and cure for allergies and asthma.
